Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intravenous (IV) Iron Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Ferric Carboxymaltose
1.2.3 Iron Sucrose
1.2.4 Iron Dextran
1.2.5 Others
1.3 Market by Application
1.3.1 Global Intravenous (IV) Iron Therapy Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Nephrology
1.3.3 Gynecology & Obstetrics
1.3.4 Gastroenterology
1.3.5 Oncology
1.3.6 Cardiology
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Intravenous (IV) Iron Therapy Market Perspective (2018-2033)
2.2 Intravenous (IV) Iron Therapy Growth Trends by Region
2.2.1 Global Intravenous (IV) Iron Therapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Intravenous (IV) Iron Therapy Historic Market Size by Region (2018-2023)
2.2.3 Intravenous (IV) Iron Therapy Forecasted Market Size by Region (2024-2033)
2.3 Intravenous (IV) Iron Therapy Market Dynamics
2.3.1 Intravenous (IV) Iron Therapy Industry Trends
2.3.2 Intravenous (IV) Iron Therapy Market Drivers
2.3.3 Intravenous (IV) Iron Therapy Market Challenges
2.3.4 Intravenous (IV) Iron Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Intravenous (IV) Iron Therapy Players by Revenue
3.1.1 Global Top Intravenous (IV) Iron Therapy Players by Revenue (2018-2023)
3.1.2 Global Intravenous (IV) Iron Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Intravenous (IV) Iron Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Intravenous (IV) Iron Therapy Revenue
3.4 Global Intravenous (IV) Iron Therapy Market Concentration Ratio
3.4.1 Global Intravenous (IV) Iron Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intravenous (IV) Iron Therapy Revenue in 2022
3.5 Intravenous (IV) Iron Therapy Key Players Head office and Area Served
3.6 Key Players Intravenous (IV) Iron Therapy Product Solution and Service
3.7 Date of Enter into Intravenous (IV) Iron Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Intravenous (IV) Iron Therapy Breakdown Data by Type
4.1 Global Intravenous (IV) Iron Therapy Historic Market Size by Type (2018-2023)
4.2 Global Intravenous (IV) Iron Therapy Forecasted Market Size by Type (2024-2033)
5 Intravenous (IV) Iron Therapy Breakdown Data by Application
5.1 Global Intravenous (IV) Iron Therapy Historic Market Size by Application (2018-2023)
5.2 Global Intravenous (IV) Iron Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Intravenous (IV) Iron Therapy Market Size (2018-2033)
6.2 North America Intravenous (IV) Iron Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Intravenous (IV) Iron Therapy Market Size by Country (2018-2023)
6.4 North America Intravenous (IV) Iron Therapy Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Intravenous (IV) Iron Therapy Market Size (2018-2033)
7.2 Europe Intravenous (IV) Iron Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Intravenous (IV) Iron Therapy Market Size by Country (2018-2023)
7.4 Europe Intravenous (IV) Iron Therapy Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Intravenous (IV) Iron Therapy Market Size (2018-2033)
8.2 Asia-Pacific Intravenous (IV) Iron Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Intravenous (IV) Iron Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Intravenous (IV) Iron Therapy Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Intravenous (IV) Iron Therapy Market Size (2018-2033)
9.2 Latin America Intravenous (IV) Iron Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Intravenous (IV) Iron Therapy Market Size by Country (2018-2023)
9.4 Latin America Intravenous (IV) Iron Therapy Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Intravenous (IV) Iron Therapy Market Size (2018-2033)
10.2 Middle East & Africa Intravenous (IV) Iron Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Intravenous (IV) Iron Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Intravenous (IV) Iron Therapy Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Intravenous (IV) Iron Therapy Introduction
11.1.4 Sanofi Revenue in Intravenous (IV) Iron Therapy Business (2018-2023)
11.1.5 Sanofi Recent Development
11.2 Allergan
11.2.1 Allergan Company Detail
11.2.2 Allergan Business Overview
11.2.3 Allergan Intravenous (IV) Iron Therapy Introduction
11.2.4 Allergan Revenue in Intravenous (IV) Iron Therapy Business (2018-2023)
11.2.5 Allergan Recent Development
11.3 AMAG Pharmaceuticals
11.3.1 AMAG Pharmaceuticals Company Detail
11.3.2 AMAG Pharmaceuticals Business Overview
11.3.3 AMAG Pharmaceuticals Intravenous (IV) Iron Therapy Introduction
11.3.4 AMAG Pharmaceuticals Revenue in Intravenous (IV) Iron Therapy Business (2018-2023)
11.3.5 AMAG Pharmaceuticals Recent Development
11.4 Dalichi Sankyo
11.4.1 Dalichi Sankyo Company Detail
11.4.2 Dalichi Sankyo Business Overview
11.4.3 Dalichi Sankyo Intravenous (IV) Iron Therapy Introduction
11.4.4 Dalichi Sankyo Revenue in Intravenous (IV) Iron Therapy Business (2018-2023)
11.4.5 Dalichi Sankyo Recent Development
11.5 Luitpold Pharmaceuticals
11.5.1 Luitpold Pharmaceuticals Company Detail
11.5.2 Luitpold Pharmaceuticals Business Overview
11.5.3 Luitpold Pharmaceuticals Intravenous (IV) Iron Therapy Introduction
11.5.4 Luitpold Pharmaceuticals Revenue in Intravenous (IV) Iron Therapy Business (2018-2023)
11.5.5 Luitpold Pharmaceuticals Recent Development
11.6 Pharmacosmos
11.6.1 Pharmacosmos Company Detail
11.6.2 Pharmacosmos Business Overview
11.6.3 Pharmacosmos Intravenous (IV) Iron Therapy Introduction
11.6.4 Pharmacosmos Revenue in Intravenous (IV) Iron Therapy Business (2018-2023)
11.6.5 Pharmacosmos Recent Development
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Company Detail
11.7.2 Takeda Pharmaceutical Business Overview
11.7.3 Takeda Pharmaceutical Intravenous (IV) Iron Therapy Introduction
11.7.4 Takeda Pharmaceutical Revenue in Intravenous (IV) Iron Therapy Business (2018-2023)
11.7.5 Takeda Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Intravenous (IV) Iron Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Ferric Carboxymaltose
Table 3. Key Players of Iron Sucrose
Table 4. Key Players of Iron Dextran
Table 5. Key Players of Others
Table 6. Global Intravenous (IV) Iron Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Intravenous (IV) Iron Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Intravenous (IV) Iron Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Intravenous (IV) Iron Therapy Market Share by Region (2018-2023)
Table 10. Global Intravenous (IV) Iron Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Intravenous (IV) Iron Therapy Market Share by Region (2024-2033)
Table 12. Intravenous (IV) Iron Therapy Market Trends
Table 13. Intravenous (IV) Iron Therapy Market Drivers
Table 14. Intravenous (IV) Iron Therapy Market Challenges
Table 15. Intravenous (IV) Iron Therapy Market Restraints
Table 16. Global Intravenous (IV) Iron Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Intravenous (IV) Iron Therapy Market Share by Players (2018-2023)
Table 18. Global Top Intravenous (IV) Iron Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous (IV) Iron Therapy as of 2022)
Table 19. Ranking of Global Top Intravenous (IV) Iron Therapy Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Intravenous (IV) Iron Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Intravenous (IV) Iron Therapy Product Solution and Service
Table 23. Date of Enter into Intravenous (IV) Iron Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Intravenous (IV) Iron Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Intravenous (IV) Iron Therapy Revenue Market Share by Type (2018-2023)
Table 27. Global Intravenous (IV) Iron Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Intravenous (IV) Iron Therapy Revenue Market Share by Type (2024-2033)
Table 29. Global Intravenous (IV) Iron Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Intravenous (IV) Iron Therapy Revenue Market Share by Application (2018-2023)
Table 31. Global Intravenous (IV) Iron Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Intravenous (IV) Iron Therapy Revenue Market Share by Application (2024-2033)
Table 33. North America Intravenous (IV) Iron Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Intravenous (IV) Iron Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Intravenous (IV) Iron Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Intravenous (IV) Iron Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Intravenous (IV) Iron Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Intravenous (IV) Iron Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Intravenous (IV) Iron Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Intravenous (IV) Iron Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Intravenous (IV) Iron Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Intravenous (IV) Iron Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Intravenous (IV) Iron Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Intravenous (IV) Iron Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Intravenous (IV) Iron Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Intravenous (IV) Iron Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Intravenous (IV) Iron Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 48. Sanofi Company Detail
Table 49. Sanofi Business Overview
Table 50. Sanofi Intravenous (IV) Iron Therapy Product
Table 51. Sanofi Revenue in Intravenous (IV) Iron Therapy Business (2018-2023) & (US$ Million)
Table 52. Sanofi Recent Development
Table 53. Allergan Company Detail
Table 54. Allergan Business Overview
Table 55. Allergan Intravenous (IV) Iron Therapy Product
Table 56. Allergan Revenue in Intravenous (IV) Iron Therapy Business (2018-2023) & (US$ Million)
Table 57. Allergan Recent Development
Table 58. AMAG Pharmaceuticals Company Detail
Table 59. AMAG Pharmaceuticals Business Overview
Table 60. AMAG Pharmaceuticals Intravenous (IV) Iron Therapy Product
Table 61. AMAG Pharmaceuticals Revenue in Intravenous (IV) Iron Therapy Business (2018-2023) & (US$ Million)
Table 62. AMAG Pharmaceuticals Recent Development
Table 63. Dalichi Sankyo Company Detail
Table 64. Dalichi Sankyo Business Overview
Table 65. Dalichi Sankyo Intravenous (IV) Iron Therapy Product
Table 66. Dalichi Sankyo Revenue in Intravenous (IV) Iron Therapy Business (2018-2023) & (US$ Million)
Table 67. Dalichi Sankyo Recent Development
Table 68. Luitpold Pharmaceuticals Company Detail
Table 69. Luitpold Pharmaceuticals Business Overview
Table 70. Luitpold Pharmaceuticals Intravenous (IV) Iron Therapy Product
Table 71. Luitpold Pharmaceuticals Revenue in Intravenous (IV) Iron Therapy Business (2018-2023) & (US$ Million)
Table 72. Luitpold Pharmaceuticals Recent Development
Table 73. Pharmacosmos Company Detail
Table 74. Pharmacosmos Business Overview
Table 75. Pharmacosmos Intravenous (IV) Iron Therapy Product
Table 76. Pharmacosmos Revenue in Intravenous (IV) Iron Therapy Business (2018-2023) & (US$ Million)
Table 77. Pharmacosmos Recent Development
Table 78. Takeda Pharmaceutical Company Detail
Table 79. Takeda Pharmaceutical Business Overview
Table 80. Takeda Pharmaceutical Intravenous (IV) Iron Therapy Product
Table 81. Takeda Pharmaceutical Revenue in Intravenous (IV) Iron Therapy Business (2018-2023) & (US$ Million)
Table 82. Takeda Pharmaceutical Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Intravenous (IV) Iron Therapy Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Intravenous (IV) Iron Therapy Market Share by Type: 2022 VS 2033
Figure 3. Ferric Carboxymaltose Features
Figure 4. Iron Sucrose Features
Figure 5. Iron Dextran Features
Figure 6. Others Features
Figure 7. Global Intravenous (IV) Iron Therapy Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Intravenous (IV) Iron Therapy Market Share by Application: 2022 VS 2033
Figure 9. Nephrology Case Studies
Figure 10. Gynecology & Obstetrics Case Studies
Figure 11. Gastroenterology Case Studies
Figure 12. Oncology Case Studies
Figure 13. Cardiology Case Studies
Figure 14. Others Case Studies
Figure 15. Intravenous (IV) Iron Therapy Report Years Considered
Figure 16. Global Intravenous (IV) Iron Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global Intravenous (IV) Iron Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 18. Global Intravenous (IV) Iron Therapy Market Share by Region: 2022 VS 2033
Figure 19. Global Intravenous (IV) Iron Therapy Market Share by Players in 2022
Figure 20. Global Top Intravenous (IV) Iron Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous (IV) Iron Therapy as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Intravenous (IV) Iron Therapy Revenue in 2022
Figure 22. North America Intravenous (IV) Iron Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America Intravenous (IV) Iron Therapy Market Share by Country (2018-2033)
Figure 24. United States Intravenous (IV) Iron Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Intravenous (IV) Iron Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Intravenous (IV) Iron Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Intravenous (IV) Iron Therapy Market Share by Country (2018-2033)
Figure 28. Germany Intravenous (IV) Iron Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Intravenous (IV) Iron Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Intravenous (IV) Iron Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Intravenous (IV) Iron Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Intravenous (IV) Iron Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Intravenous (IV) Iron Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Intravenous (IV) Iron Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific Intravenous (IV) Iron Therapy Market Share by Region (2018-2033)
Figure 36. China Intravenous (IV) Iron Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Japan Intravenous (IV) Iron Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. South Korea Intravenous (IV) Iron Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Southeast Asia Intravenous (IV) Iron Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. India Intravenous (IV) Iron Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Australia Intravenous (IV) Iron Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Intravenous (IV) Iron Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America Intravenous (IV) Iron Therapy Market Share by Country (2018-2033)
Figure 44. Mexico Intravenous (IV) Iron Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Brazil Intravenous (IV) Iron Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Intravenous (IV) Iron Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa Intravenous (IV) Iron Therapy Market Share by Country (2018-2033)
Figure 48. Turkey Intravenous (IV) Iron Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Saudi Arabia Intravenous (IV) Iron Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Sanofi Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2018-2023)
Figure 51. Allergan Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2018-2023)
Figure 52. AMAG Pharmaceuticals Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2018-2023)
Figure 53. Dalichi Sankyo Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2018-2023)
Figure 54. Luitpold Pharmaceuticals Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2018-2023)
Figure 55. Pharmacosmos Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2018-2023)
Figure 56. Takeda Pharmaceutical Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed